Apellis Pharmaceuticals (NASDAQ:APLS) Price Target Raised to $31.00
Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) had its target price lifted by Scotiabank from $30.00 to $31.00 in a report issued on Wednesday,Benzinga reports. They currently have a sector perform rating on the stock. A number of other brokerages have also recently commented on APLS. Wedbush cut their target price on shares of Apellis Pharmaceuticals […]
Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) had its target price lifted by Scotiabank from $30.00 to $31.00 in a report issued on Wednesday,Benzinga reports. They currently have a sector perform rating on the stock. A number of other brokerages have also recently commented on APLS. Wedbush cut their target price on shares of Apellis Pharmaceuticals […]